Antitumor agent-173
Product Specifications
Target
Interleukin|||MMP|||TNF
Related Pathways
Apoptosis|||Proteases/Proteasome|||Immunology/Inflammation
Bioactivity
Antitumor agent-173 (Compound 4b) acts as a prodrug of Cycloicaritin and serves as a substrate for OATP2B1. It selectively inhibits the growth of tumor cells and significantly enhances the oral bioavailability of Cycloicaritin. The compound exhibits strong antitumor activity and has a favorable safety profile.
Molecular Formula
C28H31NO9
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
B2106-70 100 µL
Blimp-1 (BLIMP 1, BLIMP1, B Lymphocyte Induced Maturation Protein 1, Positive Regulatory Domain I Binding Factor 1, PR Domain Containing 1, PRDI BF1, PRDM1) discontinued
Ask
View Details 
MBS7009097-01 0.02 mg
Recombinant Bacillus amyloliquefaciens ATP synthase subunit c (atpE)
Ask
View Details 
MBS7009097-02 0.1 mg
Recombinant Bacillus amyloliquefaciens ATP synthase subunit c (atpE)
Ask
View Details MBS7009097-03 5x 0.1 mg
Recombinant Bacillus amyloliquefaciens ATP synthase subunit c (atpE)
Ask
View Details GTR15129635 1 Vial
Lentiviral mouse Angptl6 shRNA (UAS) - Lentiviral mouse Angptl6 shRNA (UAS, RFP) (25)
Ask
View Details